Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pepa Bruce"'
Autor:
Jonathan Noble, MBBS, Lee Hatter, MBBS, Allie Eathorne, BSc, Thomas Hills, DPhil, Orlagh Bean, MBBS, Pepa Bruce, MBBS, Mark Weatherall, FRACP, Richard Beasley, DSc
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100258- (2024)
Background: In New Zealand a progressive increase in budesonide/formoterol dispensing, accompanied by a reduction in dispensing of short-acting β2-agonists (SABAs), inhaled corticosteroids (ICSs), and other ICS/long-acting β2-agonists (ICSs/LABAs),
Externí odkaz:
https://doaj.org/article/91a0d1d85f41483fad7dbcfcf5bccc02
Autor:
Pepa Bruce, Lee Hatter, Claire Houghton, Ciléin Kearns, Mark Holliday, Augustus J. Anderson, Allie Eathorne, John Martindale, Alex Semprini, Mark Weatherall, Ian Pavord, Tim Harrison, Alberto Papi, Rob Horne, Richard Beasley
Publikováno v:
ERJ Open Research, Vol 9, Iss 5 (2023)
Background The stepwise approach to long-term asthma management, which traditionally incorporates short-acting β2-agonist reliever therapy, has been a core feature of asthma guidelines for over 30 years. There have been no studies, however, directly
Externí odkaz:
https://doaj.org/article/67199b054e7140a283abd401565a550f
Autor:
Pepa Bruce Metadata, Kate Ainscough, Lee Hatter, Irene Braithwaite, Lindsay R. Berry, Mark Fitzgerald, Thomas Hills, Kathy Brickell, David Cosgrave, Alex Semprini, Susan Morpeth, Scott Berry, Peter Doran, Paul Young, Richard Beasley, Alistair Nichol
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Coronavirus disease 2019 (COVID-19) has exposed the disproportionate effects of pandemics on frontline workers and the ethical imperative to provide effective prophylaxis. We present a model for a pragmatic randomised controlled t
Externí odkaz:
https://doaj.org/article/5f2f2ed710154ba992533019f0d29a5f
Autor:
Mark Weatherall, Richard Beasley, Lee Hatter, Claire Houghton, Ciléin Kearns, Thomas Hills, Emily Dickinson, Pepa Bruce, Srinidhi Krishnamoorthy, Marjan Doppen, Seyed Ali Mirjalili
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Objectives (1) Assess the distribution of skin-to-deltoid-muscle distance (SDMD) at the deltoid intramuscular (IM) injection site; (2) its relationship with demographic and anthropometric variables and (3) Consider the findings in relation to clinica
Externí odkaz:
https://doaj.org/article/40b2ceecacf648628fa60498f4345195
Autor:
James Fingleton, Mark Weatherall, Richard Beasley, Irene Braithwaite, Ian Pavord, Jenny Sparks, Lee Hatter, Helen K Reddel, Robert J Hancox, Mark Holliday, Andrew Corin, Daniela Hall, Claire Houghton, Saras Mane, John Martindale, Karen Oldfield, Donah Sabbagh, Alexandra Vohlidkova, Alberto Papi, Allie Eathorne, Pepa Bruce
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Background In randomised controlled trials, as-needed inhaled corticosteroid (ICS)-formoterol reliever therapy reduces severe exacerbation risk compared with maintenance ICS plus short-acting beta2-agonist (SABA) reliever in adolescent and adult asth
Externí odkaz:
https://doaj.org/article/adb631a75424488db9d58a80c53835d0
Autor:
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J. Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A. Byrnes, Andrew Bush, Stuart R. Dalziel, Richard Beasley
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Background Asthma is the most common chronic disease in children, many of whom are managed solely with a short-acting β2-agonist (SABA). In adults, the evidence that budesonide-formoterol as sole reliever therapy markedly reduces the risk of severe
Externí odkaz:
https://doaj.org/article/3c29e7a34e6943428140ca01f5f4b8e5
Autor:
Pepa Bruce, Kate Ainscough, Lee Hatter, Irene Braithwaite, Lindsay R. Berry, Mark Fitzgerald, Thomas Hills, Kathy Brickell, David Cosgrave, Alex Semprini, Susan Morpeth, Scott Berry, Peter Doran, Paul Young, Richard Beasley, Alistair Nichol
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/863004d5a27947c78cbe5bc6155d35b8
Autor:
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Background The Global Initiative for Asthma recommends as-needed inhaled corticosteroid (ICS)-formoterol as an alternative to maintenance ICS plus short-acting β2-agonist (SABA) reliever at step 2 of its stepwise treatment algorithm. Our aim was to
Externí odkaz:
https://doaj.org/article/a42e25055ac741ff95139473581b61a5
PATTERNS OF ASTHMA MEDICATION USE IN NEW ZEALAND FOLLOWING PUBLICATION OF NATIONAL ASTHMA GUIDELINES
Autor:
Lee Hatter, Allie Eathorne, Tom Hills, Pepa Bruce, Claire Houghton, Mark Weatherall, Richard Beasley
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice.
Publikováno v:
Thorax. 78:430-431